16.95BMarket Cap
24.90P/E TTM
Neurocrine Biosciences Inc
NBIX Cash Flow Statement
You can access the annual and quarterly cash flow statements of Neurocrine Biosciences Inc to evaluate its financial soundness and stability.
FAQs
What is operating cash flow?
Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.
How Much Operating Cash Flow Did Neurocrine Biosciences Inc Generate?
Neurocrine Biosciences Inc generated 782.70M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.
How Did Neurocrine Biosciences Inc's Operating Cash Flow Change Year Over Year?
Neurocrine Biosciences Inc's operating cash flow increased by 31.46% year over year.
What is investing cash flow?
Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.
How Much Does Neurocrine Biosciences Inc Spend on Capital Expenditures?
Neurocrine Biosciences Inc spent 34.00M on capital expenditures in the most recent quarter。
What is financing cash flow?
Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.
How Has Neurocrine Biosciences Inc's Financing Cash Flow Changed?
Neurocrine Biosciences Inc used -38.30M in financing activities in the latest quarter.
What is free cash flow and why does it matter for NBIX?
Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
What was Neurocrine Biosciences Inc’s free cash flow in the latest quarter?
Free cash flow was 748.70M reflecting a 34.37% change from the previous year.